Corrigendum to “Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria”: [Annals of Oncology 32 (2021) 950-953]

Corrigendum to “Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria”: [Annals of Oncology 32 (2021) 950-953]

The authors regret the original funding statement in this article was incorrect. The funding statement should read as follows: “This work was supported by the Mayo Clinic Breast Cancer Specialized Program of Research Excellence Grant (P50CA 116201). Dr. Goetz is the Erivan K. Haub Family Professor o...

Full description

Bibliographic Details
Main Authors: Amiri-Kordestani, L. (Author), Beaver, J.A (Author), Bhatnagar, V. (Author), Bloomquist, E. (Author), Booth, B. (Author), Cardoso, F. (Author), Fashoyin-Aje, L. (Author), Gao, J.J (Author), Goetz, M.P (Author), Hodgdon, C. (Author), Hurvitz, S.A (Author), Ison, G. (Author), Krol, D. (Author), Mauro, L. (Author), Miller, C.P (Author), Narayan, P. (Author), Osgood, C. (Author), Pazdur, R. (Author), Regan, M.M (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2022
Subjects:
erratum
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items